Inversiones Nutravalor S.A. (SNSE:NUTRAVALOR)
Chile · Delayed Price · Currency is CLP 89.99
0.00 (0.00%)
At close: Mar 27, 2026
Inversiones Nutravalor Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 388.19 | 374.71 | 379.47 | 487.55 | 357.88 | |
Revenue Growth (YoY) | 3.60% | -1.25% | -22.17% | 36.23% | 1.17% |
Cost of Revenue | 339.83 | 338.22 | 342.01 | 430.4 | 328.51 |
Gross Profit | 48.36 | 36.49 | 37.46 | 57.15 | 29.37 |
Selling, General & Admin | 31.97 | 29.82 | 33.22 | 35.82 | 32.54 |
Other Operating Expenses | -8.76 | 7.72 | 17.53 | -49.59 | 0.57 |
Operating Expenses | 23.22 | 37.54 | 50.76 | -13.77 | 33.11 |
Operating Income | 25.14 | -1.05 | -13.3 | 70.92 | -3.75 |
Interest Expense | -15.37 | -16.74 | -17.29 | -11.55 | -8.16 |
Interest & Investment Income | 12.82 | 13.38 | 15.36 | 9.72 | 3.27 |
Earnings From Equity Investments | -18.03 | -24.68 | -6.66 | 6.75 | 16.57 |
Currency Exchange Gain (Loss) | 0.85 | -0.75 | -2.37 | -0.42 | -0.1 |
Other Non Operating Income (Expenses) | 0 | - | - | - | - |
EBT Excluding Unusual Items | 5.42 | -29.84 | -24.26 | 75.43 | 7.83 |
Gain (Loss) on Sale of Investments | - | - | - | 0.48 | 0.06 |
Gain (Loss) on Sale of Assets | 2.1 | 0.14 | 0.41 | 2.72 | -0.46 |
Asset Writedown | -0.8 | -1.23 | -0.63 | -0.12 | -0.75 |
Legal Settlements | - | - | - | - | -0.59 |
Other Unusual Items | -0.11 | -0.02 | -0.26 | -0.11 | -0.09 |
Pretax Income | 6.62 | -30.93 | -24.66 | 78.55 | 6.07 |
Income Tax Expense | 10.27 | 0.25 | -0.71 | 19.23 | 0.42 |
Earnings From Continuing Operations | -3.65 | -31.18 | -23.95 | 59.32 | 5.65 |
Earnings From Discontinued Operations | - | - | - | 7.75 | - |
Net Income to Company | -3.65 | -31.18 | -23.95 | 67.08 | 5.65 |
Minority Interest in Earnings | -4.96 | 6.57 | 8.3 | -27.13 | -2.55 |
Net Income | -8.62 | -24.61 | -15.65 | 39.95 | 3.1 |
Net Income to Common | -8.62 | -24.61 | -15.65 | 39.95 | 3.1 |
Net Income Growth | - | - | - | 1188.13% | - |
Shares Outstanding (Basic) | 311 | 311 | 313 | 311 | 310 |
Shares Outstanding (Diluted) | 311 | 311 | 313 | 311 | 310 |
Shares Change (YoY) | 0.10% | -0.75% | 0.70% | 0.26% | 0.36% |
EPS (Basic) | -0.03 | -0.08 | -0.05 | 0.13 | 0.01 |
EPS (Diluted) | -0.03 | -0.08 | -0.05 | 0.13 | 0.01 |
EPS Growth | - | - | - | 1184.79% | - |
Free Cash Flow | -32.87 | 19.03 | 53.22 | 8.88 | -16.03 |
Free Cash Flow Per Share | -0.11 | 0.06 | 0.17 | 0.03 | -0.05 |
Dividend Per Share | - | - | - | 0.039 | 0.003 |
Dividend Growth | - | - | - | 1186.67% | - |
Gross Margin | 12.46% | 9.74% | 9.87% | 11.72% | 8.21% |
Operating Margin | 6.48% | -0.28% | -3.50% | 14.55% | -1.05% |
Profit Margin | -2.22% | -6.57% | -4.13% | 8.19% | 0.87% |
Free Cash Flow Margin | -8.47% | 5.08% | 14.02% | 1.82% | -4.48% |
EBITDA | 39.4 | 14.21 | 1.83 | 89.41 | 19.3 |
EBITDA Margin | 10.15% | 3.79% | 0.48% | 18.34% | 5.39% |
D&A For EBITDA | 14.26 | 15.26 | 15.13 | 18.49 | 23.05 |
EBIT | 25.14 | -1.05 | -13.3 | 70.92 | -3.75 |
EBIT Margin | 6.48% | -0.28% | -3.50% | 14.55% | -1.05% |
Effective Tax Rate | 155.19% | - | - | 24.48% | 6.95% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.